No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acyclovir / administration & dosage
-
Acyclovir / therapeutic use
-
Adolescent
-
Adult
-
Antibodies, Viral / blood
-
Antigens, Viral / blood
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use
-
Child
-
Child, Preschool
-
Cytomegalovirus / immunology
-
Cytomegalovirus / physiology
-
Cytomegalovirus Infections / drug therapy
-
Cytomegalovirus Infections / epidemiology*
-
Cytomegalovirus Infections / prevention & control
-
Cytomegalovirus Infections / transmission
-
Disease-Free Survival
-
Ethnicity / statistics & numerical data
-
Female
-
Foscarnet / administration & dosage
-
Foscarnet / therapeutic use
-
Ganciclovir / administration & dosage
-
Ganciclovir / therapeutic use
-
Graft vs Host Disease / epidemiology
-
Hematopoietic Stem Cell Transplantation* / adverse effects
-
Humans
-
Infant
-
Infant, Newborn
-
Living Donors
-
Male
-
Middle Aged
-
Myeloablative Agonists / adverse effects
-
Postoperative Complications / epidemiology*
-
Premedication
-
Proportional Hazards Models
-
Recurrence
-
Tissue Donors*
-
Transplantation Conditioning / adverse effects
-
Transplantation, Homologous / adverse effects
-
Virus Activation
-
Young Adult
Substances
-
Antibodies, Viral
-
Antigens, Viral
-
Antiviral Agents
-
Myeloablative Agonists
-
Foscarnet
-
Ganciclovir
-
Acyclovir